Clinical Trial Update: Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia [Phase 2]

View source ↗

Summary

Phase 2 dose-finding and safety study of SHR4640 in hyperuricemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Hyperuricemia | Phase 2 | Status: COMPLETED